Labcorp (LH)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$283.76-0.22%
Close 2026-07-07 · 1-day change
Reading LH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LH free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading LH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LH free→QuarterlyIQ Insights · LH
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $283.76. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $284 LH trades at 17× p/e, below its 27× p/e peer median. Our $331 fair value sits above the price. It's a high-confidence read. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $343.83 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $336.37 | — | — | Hist. CAGR | high |
| graham number | 12M | $199.80 | — | — | TTM | high |
| Mgmt guidance | 12M | $478.13 | 26.6 | 17.98 | Mgmt | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $334.22 |
| 15.3 |
| 26.29 |
| TTM |
| high |
| Peer P/FCF | 12M | $332.64 | 19.9 | 16.69 | TTM | high |
| Peer P/E | 12M | $448.20 | 26.6 | 16.85 | TTM | high |
| Peer P/S | 12M | $562.92 | 3.3 | 170.62 | TTM | high |
| PEG | 12M | $474.59 | 28.2 | 16.85 | TTM | high |
| residual income | 12M | $140.66 | — | — | TTM | high |
| Own P/E history | 12M | $261.09 | 15.5 | 16.85 | TTM | high |
| triangulated | 12M | $464.34 | 26.6 | 17.46 | Triangulated | high |
| Mgmt guidance | 3Y | $638.57 | 26.6 | 24.01 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $364.65 | 19.9 | 18.30 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $551.10 | 26.6 | 20.72 | Analyst | medium |
| Peer P/S | 3Y | $654.02 | 3.3 | 198.23 | guidance | medium |
| PEG | 3Y | $583.54 | 28.2 | 20.72 | Analyst | medium |
| Own P/E history | 3Y | $321.03 | 15.5 | 20.72 | Analyst | medium |
| Mgmt guidance | 5Y | $774.44 | 26.6 | 29.11 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $387.69 | 19.9 | 19.46 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $597.29 | 26.6 | 22.45 | Analyst | high |
| Peer P/S | 5Y | $708.84 | 3.3 | 214.85 | guidance | high |
| PEG | 5Y | $632.45 | 28.2 | 22.45 | Analyst | high |
| Own P/E history | 5Y | $347.94 | 15.5 | 22.45 | Analyst | high |